Separately, symptoms lasting beyond three weeks, or severe vomiting, persistent abdominal pain, or signs of dehydration at any point, call for immediate evaluation to rule out pancreatitis or gastroparesis
The risk of reduced effectiveness or unknown degradation byproducts outweighs any savings from reusing old medication
Older patients may have other health conditions or take medications that could interact with semaglutide
More serious risks disclosed by HumeCare include acute pancreatitis, acute gallbladder disease, low blood sugar (particularly relevant for anyone also taking insulin or sulfonylureas), acute kidney injury related to dehydration, and serious allergic reactions
If irritation occurs, discontinue use and consult a qualified healthcare professional